The clinical trial of SAL0114 tablets was approved

2022-07-16 0 By

E company news, letter Litai (002294) February 16 evening announcement, recently, the company received the State Food and Drug Administration approved the issuance of the “clinical trial approval notice”, agreed to SAL0114 tablets to carry out clinical trials.SAL0114 tablets are compound preparations independently developed by the company and intended to apply for indications for severe depression.